111 Capital Charles River Laboratories International, Inc. Transaction History
111 Capital
- $528 Billion
- Q3 2025
A detailed history of 111 Capital transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, 111 Capital holds 1,447 shares of CRL stock, worth $242,821. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,447Holding current value
$242,821% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
642Shares Held
51.6MCall Options Held
194KPut Options Held
174K-
Vanguard Group Inc Valley Forge, PA5.84MShares$980 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$854 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.19MShares$535 Million0.09% of portfolio
-
Allspring Global Investments Holdings, LLC2.18MShares$365 Million0.61% of portfolio
-
State Street Corp Boston, MA1.83MShares$307 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.54B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...